Gender Affirming Hormone Treatment for Trans Adolescents: A Four Principles Analysis.

Area of Science:

• Biomedical Ethics
• Adolescent Medicine
• Transgender Health

Background:

• Gender affirming hormone treatment is crucial for trans adolescents, aiding development of gender-congruent secondary sexual characteristics.
• Empirical evidence increasingly supports the psychological and social well-being benefits of this treatment for trans youth.
• Recent severe restrictions in several countries highlight a debate on the ethics and potential harms versus benefits of this care.

Purpose of the Study:

• To conduct a systematic and comprehensive philosophical analysis of the ethics surrounding gender affirming hormone treatment for trans adolescents.
• To evaluate the ethical considerations using the four principles of biomedical ethics: beneficence, nonmaleficence, autonomy, and justice.

Main Methods:

• Philosophical analysis.
• Application of the four principles of biomedical ethics (beneficence, nonmaleficence, autonomy, justice) to gender affirming hormone treatment for trans adolescents.

Main Results:

• The analysis indicates that access to gender affirming hormone treatment for consenting trans adolescents is ethically supported by the principles of biomedical ethics.
• Current restrictions on this treatment are ethically unjustified based on the established ethical framework.

Conclusions:

• The provision of gender affirming hormone treatment for consenting trans adolescents is ethically mandated.
• Restrictions on access to this essential care for trans adolescents are ethically wrong and should be reconsidered.